{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,6]],"date-time":"2026-11-06T05:30:06Z","timestamp":1793943006038,"version":"4.8.0"},"reference-count":31,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T00:00:00Z","timestamp":1791504000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100004897","name":"European Organisation for Research and Treatment of Cancer","doi-asserted-by":"publisher","award":["006 2020"],"award-info":[{"award-number":["006 2020"]}],"id":[{"id":"10.13039\/501100004897","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","thegreenjournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Radiotherapy and Oncology"],"published-print":{"date-parts":[[2026,12]]},"DOI":"10.1016\/j.radonc.2026.111817","type":"journal-article","created":{"date-parts":[[2026,10,10]],"date-time":"2026-10-10T06:27:22Z","timestamp":1791613642000},"page":"111817","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["From patient-reported outcome scores to clinical meaning: defining thresholds for clinical importance for the EORTC QLQ-PR25 questionnaire for patients with prostate cancer"],"prefix":"10.1016","volume":"225","author":[{"ORCID":"https:\/\/orcid.org\/0009-0003-1711-1604","authenticated-orcid":false,"given":"Samuel M.","family":"Vorbach","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Micha J.","family":"Pilz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maike","family":"Thumfart","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lionne D.F.","family":"Venderbos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan I.","family":"Arraras","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4122-2323","authenticated-orcid":false,"given":"Ren\u00e9e","family":"Bultijnck","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ronita","family":"Mahilall","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1170-1702","authenticated-orcid":false,"given":"Esther","family":"Jimenez-Jimenez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J\u00f6rg-Andreas","family":"M\u00fcller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heike","family":"Schmidt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2807-4525","authenticated-orcid":false,"given":"Romaana","family":"Mir","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2964-1891","authenticated-orcid":false,"given":"Tara","family":"Chalk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John","family":"Ramage","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lisa","family":"Storz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0000-3110-8389","authenticated-orcid":false,"given":"Anna M.M.","family":"Thurner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2744-5950","authenticated-orcid":false,"given":"Johannes M.","family":"Giesinger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.radonc.2026.111817_b0005","doi-asserted-by":"crossref","first-page":"1683","DOI":"10.1016\/S0140-6736(24)00651-2","article-title":"The Lancet Commission on prostate cancer: planning for the surge in cases","volume":"403","author":"James","year":"2024","journal-title":"Lancet"},{"key":"10.1016\/j.radonc.2026.111817_b0010","doi-asserted-by":"crossref","first-page":"1547","DOI":"10.1056\/NEJMoa2214122","article-title":"Fifteen-year outcomes after monitoring, surgery, or radiotherapy for prostate cancer","volume":"388","author":"Hamdy","year":"2023","journal-title":"N Engl J Med"},{"key":"10.1016\/j.radonc.2026.111817_b0015","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1016\/j.eururo.2024.08.030","article-title":"Radical prostatectomy versus stereotactic radiotherapy for clinically localised prostate cancer: results of the PACE-a randomised trial","volume":"86","author":"van As","year":"2024","journal-title":"Eur Urol"},{"key":"10.1016\/j.radonc.2026.111817_b0020","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1056\/NEJMp1611252","article-title":"Patient-reported outcomes - harnessing patients' voices to improve clinical care","volume":"376","author":"Basch","year":"2017","journal-title":"N Engl J Med"},{"key":"10.1016\/j.radonc.2026.111817_b0025","doi-asserted-by":"crossref","first-page":"878","DOI":"10.1016\/j.annonc.2022.04.007","article-title":"The role of patient-reported outcome measures in the continuum of cancer clinical care: ESMO Clinical Practice Guideline","volume":"33","author":"Di Maio","year":"2022","journal-title":"Ann Oncol"},{"key":"10.1016\/j.radonc.2026.111817_b0030","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1007\/s40268-024-00478-2","article-title":"The Importance of Patient Reported Outcomes in Oncology Clinical Trials and Clinical Practice to Inform Regulatory and Healthcare Decision-making","volume":"24","author":"Bellino","year":"2024","journal-title":"Drugs R D"},{"key":"10.1016\/j.radonc.2026.111817_b0035","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1186\/s43058-024-00654-0","article-title":"Facilitators and barriers to implementing patient-reported outcomes in clinical oncology practice: a systematic review based on the consolidated framework for implementation research","volume":"5","author":"Lyu","year":"2024","journal-title":"Implement Sci Commun"},{"key":"10.1016\/j.radonc.2026.111817_b0040","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1002\/jmrs.421","article-title":"A review of the barriers to using Patient-Reported Outcomes (PROs) and Patient-Reported Outcome measures (PROMs) in routine cancer care","volume":"68","author":"Nguyen","year":"2021","journal-title":"J Med Radiat Sci"},{"key":"10.1016\/j.radonc.2026.111817_b0045","doi-asserted-by":"crossref","DOI":"10.1007\/s11136-026-04205-z","article-title":"Barriers and facilitators for implementing patient-reported outcome measures in oncology practices: an umbrella review","volume":"35","author":"Rammant","year":"2026","journal-title":"Qual Life Res"},{"key":"10.1016\/j.radonc.2026.111817_b0050","doi-asserted-by":"crossref","first-page":"1040","DOI":"10.1186\/s12889-022-13211-y","article-title":"EORTC QLQ-C30 general population normative data for Italy by sex, age and health condition: an analysis of 1,036 individuals","volume":"22","author":"Pilz","year":"2022","journal-title":"BMC Public Health"},{"key":"10.1016\/j.radonc.2026.111817_b0055","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.ejca.2019.10.031","article-title":"Reference values for the EORTC QLQ-C30 in early and metastatic breast cancer","volume":"125","author":"Mierzynska","year":"2020","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.radonc.2026.111817_b0060","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/j.ejca.2023.04.027","article-title":"Minimally important differences for interpreting EORTC QLQ-C30 change scores over time: a synthesis across 21 clinical trials involving nine different cancer types","volume":"188","author":"Musoro","year":"2023","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.radonc.2026.111817_b0065","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jclinepi.2019.10.003","article-title":"Thresholds for clinical importance were established to improve interpretation of the EORTC QLQ-C30 in clinical practice and research","volume":"118","author":"Giesinger","year":"2020","journal-title":"J Clin Epidemiol"},{"key":"10.1016\/j.radonc.2026.111817_b0070","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1186\/s12955-025-02387-7","article-title":"The current use and application of thresholds for clinical importance of the EORTC QLQ-C30, the EORTC CAT core and the EORTC QLQ-C15-PAL- a systematic scoping review","volume":"23","author":"Pilz","year":"2025","journal-title":"Health Qual Life Outcomes"},{"key":"10.1016\/j.radonc.2026.111817_b0075","doi-asserted-by":"crossref","first-page":"2418","DOI":"10.1016\/j.ejca.2008.07.030","article-title":"An international field study of the EORTC QLQ-PR25: a questionnaire for assessing the health-related quality of life of patients with prostate cancer","volume":"44","author":"van Andel","year":"2008","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.radonc.2026.111817_b0080","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejca.2025.115392","article-title":"Flexibility in patient-reported outcome and health-related quality of life measurement: the EORTC Quality of Life Group measurement strategy","volume":"220","author":"Piccinin","year":"2025","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.radonc.2026.111817_b0085","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1093\/jnci\/85.5.365","article-title":"The European Organization for Research and Treatment of Cancer QLQ-C30: a quality-of-life instrument for use in international clinical trials in oncology","volume":"85","author":"Aaronson","year":"1993","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.radonc.2026.111817_b0090","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1186\/1472-6947-12-126","article-title":"The Computer-based Health Evaluation Software (CHES): a software for electronic patient-reported outcome monitoring","volume":"12","author":"Holzner","year":"2012","journal-title":"BMC Med Inf Decis Making"},{"key":"10.1016\/j.radonc.2026.111817_b0095","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1089\/jpm.2020.0159","article-title":"Evaluating the Thresholds for Clinical Importance of the EORTC QLQ-C15-PAL in patients Receiving Palliative Treatment","volume":"24","author":"Pilz","year":"2021","journal-title":"J Palliat Med"},{"key":"10.1016\/j.radonc.2026.111817_b0100","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejca.2025.116134","article-title":"Facilitating the interpretation of the multidimensional EORTC QLQ-FA12 fatigue questionnaire: establishing thresholds for clinical importance","volume":"232","author":"Blickle","year":"2026","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.radonc.2026.111817_b0105","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1002\/pon.4548","article-title":"A cross-cultural convergent parallel mixed methods study of what makes a cancer-related symptom or functional health problem clinically important","volume":"27","author":"Giesinger","year":"2018","journal-title":"Psychooncology"},{"key":"10.1016\/j.radonc.2026.111817_b0110","doi-asserted-by":"crossref","first-page":"1315","DOI":"10.1097\/JTO.0b013e3181ec173d","article-title":"Receiver operating characteristic curve in diagnostic test assessment","volume":"5","author":"Mandrekar","year":"2010","journal-title":"J Thorac Oncol"},{"key":"10.1016\/j.radonc.2026.111817_b0115","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/j.ejca.2016.05.020","article-title":"Long-term quality of life among localised prostate cancer survivors: QALIPRO population-based study","volume":"63","author":"Kerleau","year":"2016","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.radonc.2026.111817_b0120","article-title":"Patient-reported outcomes 12 years after localized prostate cancer treatment","volume":"2(4):EVIDoa2300018","author":"Donovan","year":"2023","journal-title":"NEJM Evid"},{"key":"10.1016\/j.radonc.2026.111817_b0125","doi-asserted-by":"crossref","DOI":"10.2196\/26022","article-title":"Using the Computer-based Health Evaluation System (CHES) to support Self-management of Symptoms and Functional Health: Evaluation of Hematological Patient use of a Web-based Patient Portal","volume":"23","author":"Lehmann","year":"2021","journal-title":"J Med Internet Res"},{"key":"10.1016\/j.radonc.2026.111817_b0130","article-title":"Physicians' Perceptions of Clinical Utility of a Digital Health Tool for Electronic Patient-Reported Outcome monitoring in Real-Life Hematology Practice. evidence from the GIMEMA-ALLIANCE Platform. Front","volume":"12","author":"Efficace","year":"2022","journal-title":"Oncol"},{"key":"10.1016\/j.radonc.2026.111817_b0135","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1186\/s41687-022-00478-3","article-title":"An implementation study of electronic assessment of patient-reported outcomes in inpatient radiation oncology","volume":"6","author":"Nordhausen","year":"2022","journal-title":"J Patient Rep Outcomes"},{"key":"10.1016\/j.radonc.2026.111817_b0140","doi-asserted-by":"crossref","DOI":"10.2196\/46017","article-title":"Adherence to Patient-Reported Symptom monitoring and subsequent Clinical Interventions for patients with Multiple Myeloma in Outpatient Care: Longitudinal Observational Study","volume":"25","author":"Lehmann","year":"2023","journal-title":"J Med Internet Res"},{"key":"10.1016\/j.radonc.2026.111817_b0145","doi-asserted-by":"crossref","first-page":"1593","DOI":"10.1111\/1471-0528.17567","article-title":"Patient-initiated follow-up in women with early-stage endometrial cancer: a long-term follow-up of the OPAL trial","volume":"130","author":"Rulanda","year":"2023","journal-title":"BJOG"},{"key":"10.1016\/j.radonc.2026.111817_b0150","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1136\/ard.2004.023028","article-title":"Evaluation of clinically relevant states in patient reported outcomes in knee and hip osteoarthritis: the patient acceptable symptom state","volume":"64","author":"Tubach","year":"2005","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.radonc.2026.111817_b0155","doi-asserted-by":"crossref","first-page":"e1297","DOI":"10.1097\/PR9.0000000000001297","article-title":"Establishing the patient acceptable symptom state for patient-reported pain outcomes 6 months after breast cancer surgery","volume":"10","author":"Kang","year":"2025","journal-title":"Pain Rep"}],"container-title":["Radiotherapy and Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0167814026006572?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0167814026006572?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,11,6]],"date-time":"2026-11-06T05:13:20Z","timestamp":1793942000000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0167814026006572"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,12]]},"references-count":31,"alternative-id":["S0167814026006572"],"URL":"https:\/\/doi.org\/10.1016\/j.radonc.2026.111817","relation":{},"ISSN":["0167-8140"],"issn-type":[{"value":"0167-8140","type":"print"}],"subject":[],"published":{"date-parts":[[2026,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"From patient-reported outcome scores to clinical meaning: defining thresholds for clinical importance for the EORTC QLQ-PR25 questionnaire for patients with prostate cancer","name":"articletitle","label":"Article Title"},{"value":"Radiotherapy and Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.radonc.2026.111817","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Author(s). Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"111817"}}